Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis
- PMID: 21737586
- PMCID: PMC3208650
- DOI: 10.1164/rccm.201105-0816OC
Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis
Abstract
Rationale: Most children with cystic fibrosis (CF) experience a slow decline in spirometry, although some children continue to be at risk for more significant lung disease progression. Chest computed tomography (CT) scans have been shown to be more sensitive to changes in lung disease than spirometry and may provide a means for predicting future lung disease progression.
Objectives: We hypothesized that Brody chest CT scan scores obtained in 2000 in a prospectively monitored cohort of children with CF would be associated with the most recent measures of lung disease severity.
Methods: Brody chest CT scan scores were calculated for 81 children enrolled in the Wisconsin CF Neonatal Screening Project. Multivariable linear regression was used to determine associations between Brody scores and the most recent (age 21 yr or June 30, 2010, whichever was later) measures of CF lung disease.
Measurements and main results: The mean observation time after the chest CT scan was 7.5 years. Brody chest CT scan scores were significantly associated with the most recent measures of spirometry (P < 0.001) and Wisconsin and Brasfield chest radiograph scores (P < 0.001). The strength of this association was much stronger than spirometry obtained near the time of the chest CT scan (P < 0.01) but not chest radiograph scores.
Conclusions: Chest CT scan scores are associated with future lung disease severity, and quantitative chest imaging(chest CT scan and chest radiograph scores) is more strongly associated with future lung disease severity than measures of spirometry. These findings may help clinicians identify patients at risk of future lung disease progression.
Figures




Comment in
-
The importance of imaging in cystic fibrosis.Am J Respir Crit Care Med. 2011 Oct 1;184(7):751-2. doi: 10.1164/rccm.201108-1435ED. Am J Respir Crit Care Med. 2011. PMID: 21965011 No abstract available.
Similar articles
-
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.Pediatr Pulmonol. 2012 Jun;47(6):567-73. doi: 10.1002/ppul.21621. Epub 2011 Dec 13. Pediatr Pulmonol. 2012. PMID: 22170734 Free PMC article.
-
Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis.Ann Am Thorac Soc. 2015 Jan;12(1):64-9. doi: 10.1513/AnnalsATS.201407-338OC. Ann Am Thorac Soc. 2015. PMID: 25474182 Free PMC article. Clinical Trial.
-
Is sweat chloride predictive of severity of cystic fibrosis lung disease assessed by chest computed tomography?Pediatr Pulmonol. 2017 Sep;52(9):1135-1141. doi: 10.1002/ppul.23739. Epub 2017 Jun 6. Pediatr Pulmonol. 2017. PMID: 28586522
-
Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography.Paediatr Respir Rev. 2014 Mar;15(1):92-7. doi: 10.1016/j.prrv.2013.05.003. Epub 2013 Jul 2. Paediatr Respir Rev. 2014. PMID: 23830321 Review.
-
High-resolution CT scanning: potential outcome measure.Curr Opin Pulm Med. 2004 Nov;10(6):537-41. doi: 10.1097/01.mcp.0000142924.38801.45. Curr Opin Pulm Med. 2004. PMID: 15510063 Review.
Cited by
-
High-dimensional multinomial multiclass severity scoring of COVID-19 pneumonia using CT radiomics features and machine learning algorithms.Sci Rep. 2022 Sep 1;12(1):14817. doi: 10.1038/s41598-022-18994-z. Sci Rep. 2022. PMID: 36050434 Free PMC article.
-
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.Eur Respir Rev. 2022 Mar 23;31(163):210173. doi: 10.1183/16000617.0173-2021. Print 2022 Mar 31. Eur Respir Rev. 2022. PMID: 35321929 Free PMC article.
-
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.Pediatr Pulmonol. 2012 Jun;47(6):567-73. doi: 10.1002/ppul.21621. Epub 2011 Dec 13. Pediatr Pulmonol. 2012. PMID: 22170734 Free PMC article.
-
Computed tomography dose optimisation in cystic fibrosis: A review.World J Radiol. 2016 Apr 28;8(4):331-41. doi: 10.4329/wjr.v8.i4.331. World J Radiol. 2016. PMID: 27158420 Free PMC article. Review.
-
Brasfield and Wisconsin scoring systems have equal value as outcome assessment tools of cystic fibrosis lung disease.Pediatr Radiol. 2014 May;44(5):529-34. doi: 10.1007/s00247-013-2848-1. Epub 2013 Dec 27. Pediatr Radiol. 2014. PMID: 24370794
References
-
- CF Foundation Cystic Fibrosis Foundation Patient Registry 2008 Annual Data Report. Bethesda, MD: CF Foundation; 2009
-
- Amin R, Lam M, Dupuis A, Ratjen F. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis. Pediatr Pulmonol 2011;46:554–558 - PubMed
-
- Konstan M, Morgan W, Butler S, Pasta D, Craib M, Silva S, Stokes D, Wohl M, Wagener J, Regelmann W, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007;151:134–139e1 - PubMed
-
- Brody A, Klein J, Molina P, Quan J, Bean J, Wilmott R. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32–38 - PubMed